Analecto

Transforms the treatment of chronic infections by providing precise detection and analysis of infected cells, using CRISPR/Cas DNA cleavage and high-fidelity DNA sequencing. The focus is on detecting HIV-infected cells, enabling personalized treatment plans and potentially reducing long-term HIV treatment duration and cost.

LinkedIn

Visit site